# Phase 3: Cross-Page Features — Verification & Completion Report

**Project:** DiaCare Analytics  
**Date:** October 25, 2026  
**Status:** **Phase 3 Completed & Verified**  
**Environment:** Python 3.12.15 (`scikit-learn==1.9.1`, `xgboost==3.4.1`, Flask 3.1.3, pandas 3.1.0, numpy 2.5.4, joblib 1.6.0)

---

## 1. Executive Summary

Phase 3 delivered the platform's flagship cross-model capabilities:
1. **Unified Patient Summary (`/patient-summary`):** A single master patient intake form running all applicable models simultaneously with an integrated clinical cross-model recommendation engine.
2. **Dashboard Cohort KPIs:** Real-time benchmark indicators (69,970 stays cohort, 4.3d median stay, 8.2% readmission decision cutoff, 6 active models).
3. **Clinical Severity Progression Palette:** Monochromatic degrees of blue (Light Sky Blue for Low severity, Darker Royal Blue for Moderate/Elevated severity) culminating in Danger Red for critical/alert states.
4. **Standardized Decision Support Advisory:** Institutional advisory banner systematically placed on all evaluation results across all models.

---

## 2. Core Deliverables

### A. Unified Patient Summary (`app/services/summary_service.py`)
- **Single Master Form:** Consolidated 35 patient fields organized into 5 logical sections (Demographics, Admission, Utilisation, Diagnoses, Medications & Diabetes).
- **Simultaneous Model Execution:** `run_all(form, role)` translates and prepares model-specific matrices in a single call, executing:
  - *Reception Staff:* 3 models (Length of Stay, Discharge Destination, Medication Load).
  - *Attending Physicians:* All 6 models (+ Readmission Screening, HbA1c Treatment, Patient Phenotyping).
- **Integrated Clinical Rule Engine (`_build_combined_rules`):** Evaluates multi-model risk combinations:
  - *Rule 1 (Danger):* High Polypharmacy ($\ge 18$ drugs) + Long Stay ($>3$ days) $\rightarrow$ Escalate multidisciplinary pharmacy review.
  - *Rule 2 (Danger):* Transfer Alert + Elevated Readmission Risk $\rightarrow$ Early transitional care coordination.
  - *Rule 3 (Warning):* HbA1c Not Measured + Elevated Readmission $\rightarrow$ Order inpatient HbA1c prior to discharge (OR $\approx 0.904$).
  - *Rule 4 (Warning):* Complex Phenotype (Profile 1) + Long Stay $\rightarrow$ Multidisciplinary team review from Day 1.
  - *Rule 5 (Success/Routine):* Home Discharge + Low Medication Load $\rightarrow$ Routine discharge checklist.
- **One-Click Sample Patient Loaders:** `Routine Inpatient (Lower Risk)` and `Complex Inpatient (Higher Risk)` buttons for immediate clinical demonstrations.
- **Print Optimization:** Dedicated report printing support (`window.print()`).

### B. Standardized Decision Support Advisory Banner
Placed systematically across all single-patient evaluation results:
> **Decision Support Advisory:** DiaCare models assist clinical prioritization and transitional care allocation. They do not constitute diagnostic or prescriptive orders. Always consider the full clinical context.

### C. Clinical Severity Palette (Degrees of Blue $\rightarrow$ Red)
- **Low / Routine / Normal:** Light Sky Blue (`#0ea5e9`, text: `#0284c7`, bg: `#e0f2fe`, border: `#bae6fd`).
- **Moderate / Elevated:** Darker Royal Blue (`#175cdd`, bg: `#ebf2ff`, border: `#c7d9fc`).
- **High / Alert / Critical:** Danger Red (`#dc3545`, bg: `#fdf2f2`, border: `#fecaca`).

### D. Dashboard Cohort KPIs (`app/templates/dashboard/index.html`)
Four prominent stat cards summarizing the UCI Diabetes 130-US Hospitals benchmark:
- **69,970** Inpatient Stays Cohort
- **4.3d** Median Length of Stay
- **8.2%** Calibrated High-Risk Cutoff (11.2% base rate)
- **6** Integrated Clinical ML Models

### E. Short Interpretation & Probability Distribution Across All Models
Under "Assessment Complete" on every single evaluation page and within the Unified Patient Report:
1. **Model 1: 30-Day Readmission Risk (`readmission_single.html`):**
   - Clinical interpretation callout comparing evaluated risk with hospital average and action threshold.
   - 2-bar probability distribution (Readmission vs No Readmission) with calibrated cutoff indicator.
2. **Model 2: HbA1c & Glycemic Care (`hba1c_single.html`):**
   - Clinical interpretation callout highlighting the verified ~9.6% relative risk reduction (OR 0.904) when tested.
   - Probability distribution displaying evaluated risk, projected risk with tested HbA1c, and baseline non-readmission.
3. **Model 3: Medication Load (`medication_single.html`):**
   - Clinical interpretation callout for polypharmacy risk tiers ($\le 11$, $12\text{--}17$, $\ge 18$ medications).
   - 3-bar probability distribution with degrees-of-blue severity colors.
4. **Model 4: Discharge Destination (`discharge_single.html`):**
   - Clinical interpretation callout indicating post-acute transfer facility alert vs standard discharge pathway.
   - 4-destination probability distribution with transfer threshold marker.
5. **Model 5: Length of Stay (`los_single.html`):**
   - Clinical interpretation callout for prolonged hospitalization ($>3$ days) vs routine stay ($\le 3$ days).
   - 2-bar probability distribution with 50% cutoff indicator.
6. **Model 6: Patient Phenotyping (`profiles_patient.html`):**
   - Clinical interpretation callout comparing distance to Profile 0 (Routine) vs Profile 1 (Complex).
   - Phenotype alignment affinity distribution bars based on centroid distances.
7. **Unified Patient Report (`patient_summary/index.html`):**
   - All 6 model cards updated with concise interpretation summaries and probability distributions.
   - Renamed from "Patient Summary" to "Patient Report" across navbars, footers, headings, and routes (`/patient-report` and `/patient-summary`).
   - Fixed sample profile loader button execution by ensuring scripts are rendered on initial GET and dispatching change events.

---

## 3. Test Verification

`tests/test_phase3_summary.py` + full test suite:
- **7/7 Phase 3 Tests Pass:**
  - GET `/patient-summary` and `/patient-report` for Doctor and Reception
  - POST as Doctor evaluates all 6 models and renders integrated guidance
  - POST as Reception strictly restricts output to 3 models with zero leakage of clinical-only models
  - High-risk patient triggers danger-level cross-model rules
  - `summary_service` unit tests for direct and role-gated invocations
- **Complete Test Suite:** 26/26 tests passing across all test modules (`test_phase1_foundation`, `test_load_models`, `test_phase2_parity`, `test_phase2_routes`, `test_phase3_summary`).
- **Checksums:** 12/12 verified untouched. Ready for Phase 4.
